Risk prediction models: II. External validation, model updating, and impact assessment
Karel G.M. Moons(Utrecht University), Mark Woodward(University of Leicester), André Pascal Kengne(University of Washington), Diederick E. Grobbee(University Medical Center Utrecht), Douglas G. Altman(University of Oxford), Yvonne Vergouwe(Leiden University), Patrick Royston(MRC Clinical Trials Unit at UCL)
Cited by 1,188
Related Papers
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations
|European Journal of Epidemiology|2016|3.1k
Evaluating non-randomised intervention studies
|Health Technology Assessment|2003|2.9k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Internal validation of predictive models
|Journal of Clinical Epidemiology|2001|2.6k